{
    "id": 26167,
    "fullName": "KMT2A - GAS7",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KMT2A-GAS7 results from the fusion of KMT2A and GAS7, and leads to activation of downstream targets and transformation of cells in culture, and induces leukemia in mouse models (PMID: 26766589, PMID: 12620410).",
            "references": [
                {
                    "id": 8306,
                    "pubMedId": 12620410,
                    "title": "MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/12620410"
                },
                {
                    "id": 8304,
                    "pubMedId": 26766589,
                    "title": "Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26766589"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4297,
        "geneSymbol": "KMT2A",
        "terms": [
            "KMT2A",
            "ALL-1",
            "CXXC7",
            "HRX",
            "HTRX1",
            "MLL",
            "MLL1",
            "MLL1A",
            "TRX1",
            "WDSTS"
        ]
    },
    "variant": "KMT2A - GAS7",
    "createDate": "03/22/2017",
    "updateDate": "03/10/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 8522,
                "geneSymbol": "GAS7",
                "terms": [
                    "GAS7"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 10326,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with AMI-408 decreased growth of leukemia cells expressing KMT2A-GAS7 (MLL-GAS7) in culture, and increased survival in xenograft models (PMID:26766589).",
            "molecularProfile": {
                "id": 27356,
                "profileName": "KMT2A - GAS7"
            },
            "therapy": {
                "id": 5463,
                "therapyName": "AMI-408",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8304,
                    "pubMedId": 26766589,
                    "title": "Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26766589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27356,
            "profileName": "KMT2A - GAS7",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}